Hints and tips:
Related Special Reports
...CV6 is one of a number of promising life sciences start-ups to set up in Northern Ireland, drawn by the region’s specialised graduates and lower development costs....
...Learfield is the product of a $2bn merger in 2018 between two of the largest multimedia sports marketing groups in college sports....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...McKernan will chair the scientific advisory board of the UK’s new Neurodegeneration Initiative....
...Gisaid said it had remedied the issues by creating a new compliance board and expanding its scientific advisory council, measures that had created “a new layer of support” for users....
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...The DeepMind project is the product of three years of work with Liverpool on deploying AI, including in areas such as penalty kicks and predicting movements of players....
...Some recent buying activity on the board could signal director confidence about the refreshed strategy. Schumacher picked up €62,000-worth of shares on the Amsterdam Stock Exchange on November 22....
...The global contract development and manufacturing market, which supports pharma companies in making products and running clinical trials, is projected to grow from $72bn to $90bn over the next two years,...
...make up the backbone of pharmaceutical care....
...Drugs made by Japan’s Eisai and Eli Lilly of the US have shown promise when used early in an individual’s development of the disease....
...Overall, consultants McKinsey estimated in a report in January that AI could generate $60bn-$110bn a year for the pharmaceutical and medical-product industries by identifying compounds for possible new drugs...
...Baseimmune “has a very sophisticated way of going after everything from swine flu to [tropical disease] chikungunya and getting your products to market faster”, said David Rubin, managing director of MSD...
...“If you provide a solid rationale, investors are likely to listen,” said one board director....
...The Medicines and Healthcare products Regulatory Agency, the medicines watchdog, has lost millions of pounds in funding and access to a larger regulatory market....
...Today it’s announcing a new chief executive: Woochong Um, hitherto managing director-general at the Asian Development Bank, with a focus on the institution’s sustainable development agenda....
...— There is no reduction in demand for buy-on-board food products or related businesses such as airport food courts because these consumers eat less....
...Like most drugs, they were approved on a few years of data. “Pharmaceutical companies are forever promising hugely transformational, innovative products,” he says. “And sometimes they are....
...The deal — the terms of which were not disclosed — was made by OTB’s production arm, Staff International, and is part of a long-term strategy for improving the product development of its brands, which include...
...This year’s goal of 5 per cent gross domestic product growth is considered ambitious by analysts....
...The World Obesity Federation expects the economic cost of overweight and obesity to reach 3 per cent of global gross domestic product annually by 2035 — on par with the impact of Covid-19 in 2020....
...“Giving is business development,” argues Edward Cunningham of the Harvard Kennedy School....
...That’s just not going to get the EU on board. Essentially it’s just the old green steel club in a new wrapping....
...Battery producers are optimistic of AI revolutionising the discovery of new materials, emulating a shift seen in the pharmaceutical industry where the technology is being used to speed up the development...
...Beverly Tchang, an obesity medicine physician at Weill Cornell Medicine and diplomate of the American Board of Obesity Medicine, said the medical community was “extremely excited to have the official FDA...
International Edition